Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.

Cui K, Li X, Du Y, Tang X, Arai S, Geng Y, Xi Y, Xu H, Zhou Y, Ma W, Zhang T.

Oncotarget. 2017 May 30;8(22):36674-36684. doi: 10.18632/oncotarget.16230.

2.

Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.

van Zuuren EJ, Fedorowicz Z.

Br J Dermatol. 2016 Jul;175(1):45-61. doi: 10.1111/bjd.14486. Epub 2016 Jun 23. Review.

PMID:
26892495
3.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society (AES).

Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.

PMID:
26509855
4.

The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.

Al Khalifah RA, Flórez ID, Dennis B, Neupane B, Thabane L, Bassilious E.

Syst Rev. 2015 Sep 23;4:125. doi: 10.1186/s13643-015-0105-4. Review.

5.

Gynecomastia in Patients with Prostate Cancer: A Systematic Review.

Fagerlund A, Cormio L, Palangi L, Lewin R, Santanelli di Pompeo F, Elander A, Selvaggi G.

PLoS One. 2015 Aug 26;10(8):e0136094. doi: 10.1371/journal.pone.0136094. eCollection 2015. Review.

6.

Interventions for hirsutism (excluding laser and photoepilation therapy alone).

van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N.

Cochrane Database Syst Rev. 2015 Apr 28;(4):CD010334. doi: 10.1002/14651858.CD010334.pub2. Review.

7.

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM.

J Clin Oncol. 2015 Feb 1;33(4):332-9. doi: 10.1200/JCO.2014.58.0662. Epub 2014 Dec 22.

8.

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.

Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, Garrels K, Hotte S, Kattan MW, Raghavan D, Saad F, Taplin ME, Walker-Dilks C, Williams J, Winquist E, Bennett CL, Wootton T, Rumble RB, Dusetzina SB, Virgo KS.

J Clin Oncol. 2014 Oct 20;32(30):3436-48. doi: 10.1200/JCO.2013.54.8404. Epub 2014 Sep 8. Review.

9.

Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.

Kunath F, Grobe HR, Rücker G, Motschall E, Antes G, Dahm P, Wullich B, Meerpohl JJ.

Cochrane Database Syst Rev. 2014 Jun 30;(6):CD009266. doi: 10.1002/14651858.CD009266.pub2. Review.

PMID:
24979481
10.

Hirsutism: an evidence-based treatment update.

Somani N, Turvy D.

Am J Clin Dermatol. 2014 Jul;15(3):247-66. doi: 10.1007/s40257-014-0078-4. Review.

PMID:
24889738
11.

Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.

Domecq JP, Prutsky G, Mullan RJ, Sundaresh V, Wang AT, Erwin PJ, Welt C, Ehrmann D, Montori VM, Murad MH.

J Clin Endocrinol Metab. 2013 Dec;98(12):4646-54. doi: 10.1210/jc.2013-2374. Epub 2013 Oct 3. Review.

12.

Alopecia with endocrine therapies in patients with cancer.

Saggar V, Wu S, Dickler MN, Lacouture ME.

Oncologist. 2013;18(10):1126-34. doi: 10.1634/theoncologist.2013-0193. Epub 2013 Sep 13.

13.

Treatment of female pattern hair loss.

Hassani M, Gorouhi F, Babakoohi S, Moghadam-Kia S, Firooz A.

Skinmed. 2012 Jul-Aug;10(4):218-27. Review.

PMID:
23008939
14.

[Hormonal antiandrogens in acne treatment].

Zouboulis CC, Rabe T.

J Dtsch Dermatol Ges. 2010 Mar;8 Suppl 1:S60-74. doi: 10.1111/j.1610-0387.2009.07171.x. Review. German.

PMID:
20482693
15.

Management of acne vulgaris: an evidence-based update.

Ingram JR, Grindlay DJ, Williams HC.

Clin Exp Dermatol. 2010 Jun;35(4):351-4. doi: 10.1111/j.1365-2230.2009.03683.x. Epub 2009 Oct 23. Review.

PMID:
19874358
16.

PCOS.

Cahill D.

BMJ Clin Evid. 2009 Jan 15;2009. pii: 1408. Review.

17.

Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.

Cosma M, Swiglo BA, Flynn DN, Kurtz DM, Labella ML, Mullan RJ, Elamin MB, Erwin PJ, Montori VM.

J Clin Endocrinol Metab. 2008 Apr;93(4):1135-42. doi: 10.1210/jc.2007-2429. Epub 2008 Feb 5. Review.

PMID:
18252787
18.

Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.

Swiglo BA, Cosma M, Flynn DN, Kurtz DM, Labella ML, Mullan RJ, Erwin PJ, Montori VM.

J Clin Endocrinol Metab. 2008 Apr;93(4):1153-60. doi: 10.1210/jc.2007-2430. Epub 2008 Feb 5. Review.

PMID:
18252786
19.

A systematic review of commonly used medical treatments for hirsutism in women.

Koulouri O, Conway GS.

Clin Endocrinol (Oxf). 2008 May;68(5):800-5. Epub 2007 Nov 2. Review.

PMID:
17980017
20.

Maximal androgen blockade for the treatment of metastatic prostate cancer--a systematic review.

Lukka H, Waldron T, Klotz L, Winquist E, Trachtenberg J; Genitourinary Cancer Disease Site Group; Cancer Care Ontario Program in Evidence-based Care.

Curr Oncol. 2006 Jun;13(3):81-93.

Supplemental Content

Loading ...
Support Center